These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3913486)

  • 1. The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
    Eccleston D; Fairbairn AF; Hassanyeh F; McClelland HA; Stephens DA
    Br J Psychiatry; 1985 Dec; 147():623-30. PubMed ID: 3913486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Herrington RN; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
    Acta Psychiatr Scand Suppl; 1990; 358():136-7. PubMed ID: 1978473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.
    Peet M; Bethell MS; Coates A; Khamnee AK; Hall P; Cooper SJ; King DJ; Yates RA
    Br J Psychiatry; 1981 Aug; 139():105-11. PubMed ID: 7030442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextro-propranolol and depressive symptoms in a schizophrenic population.
    Manchanda R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):625-32. PubMed ID: 3321153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioridazine improves affective symptoms in schizophrenic patients.
    Dufresne RL; Valentino D; Kass DJ
    Psychopharmacol Bull; 1993; 29(2):249-55. PubMed ID: 8290673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some clinical and metabolic aspects of propranolol in chronic schizophrenia.
    King DJ; Turkson SN; Liddle J; Kinney CD
    Br J Psychiatry; 1980 Nov; 137():458-68. PubMed ID: 7008891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
    Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
    Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of trebenzomine and thioridazine in the treatment of schizophrenia.
    Georgotas A; Gerbino L; Jordan B; McCarthy M; Gershon S; Kleinberg D; Lautin A; Stanley M; Rotrosen J
    Psychopharmacology (Berl); 1981; 73(3):292-4. PubMed ID: 6113618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic effect of propranolol on chronic schizophrenics: study of a gradual treatment regimen.
    Elizur A; Segal Z; Yeret A; Davidson S; Atsmon A
    Psychopharmacology (Berl); 1979 Jan; 60(2):189-94. PubMed ID: 34185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrodermal activity and therapeutic response to neuroleptic treatment in chronic schizophrenic in-patients.
    Schneider SJ
    Psychol Med; 1982 Aug; 12(3):607-13. PubMed ID: 7134318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.
    Lindström LH; Persson E
    Br J Psychiatry; 1980 Aug; 137():126-30. PubMed ID: 6107136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia.
    McCreadie RG; Todd N; Livingston M; Eccleston D; Watt JA; Tait D; Crocket G; Mitchell MJ; Huitfeldt B
    Acta Psychiatr Scand; 1988 Jul; 78(1):49-56. PubMed ID: 2972165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of propranolol in chronic schizophrenia.
    Myers DH; Campbell PL; Cocks NM; Flowerdew JA; Muir A
    Br J Psychiatry; 1981 Aug; 139():118-21. PubMed ID: 7030444
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma levels and clinical effects of thioridazine and thiothixene.
    Bergling R; Mjorndal T; Oreland L; Rapp W; Wold S
    J Clin Pharmacol; 1975; 15(2-3):178-86. PubMed ID: 1091665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment in newly admitted schizophrenic patients.
    Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
    Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
    [No Abstract]   [Full Text] [Related]  

  • 19. Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication.
    Pugh CR; Steinert J; Priest RG
    Br J Psychiatry; 1983 Aug; 143():151-5. PubMed ID: 6137255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophrenia.
    Keks N; McGrath J; Lambert T; Catts S; Vaddadi K; Burrows G; Varghese F; George T; Hustig H; Burnett P
    Acta Psychiatr Scand; 1994 Nov; 90(5):358-65. PubMed ID: 7872041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.